Profil
Shmuel A. Ben-Sasson is the founder of Chiasma, Inc. (2001) and Raziel Therapeutics RT Ltd. (2012).
Dr. Ben-Sasson is also the founder of Keryx Biopharmaceuticals, Inc. Dr. Ben-Sasson is currently an Associate Professor-Experimental Medicine at The Hebrew University of Jerusalem.
Postes actifs de Shmuel A. Ben-Sasson
| Sociétés | Poste | Début |
|---|---|---|
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Shmuel A. Ben-Sasson
| Sociétés | Poste | Fin |
|---|---|---|
| CHIASMA, INC. | Fondateur | - |
Raziel Therapeutics RT Ltd.
Raziel Therapeutics RT Ltd. Pharmaceuticals: MajorHealth Technology Develops innovative technology to treat obesity disease | Fondateur | - |
| KERYX BIOPHARMACEUTICALS | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Chiasma, Inc.
Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops treatments for rare and serious chronic disease | Health Technology |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Raziel Therapeutics RT Ltd.
Raziel Therapeutics RT Ltd. Pharmaceuticals: MajorHealth Technology Develops innovative technology to treat obesity disease | Health Technology |
















